<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="zh">
	<id>https://arolstar52-zhtest.hf.space/index.php?action=history&amp;feed=atom&amp;title=5-APDI</id>
	<title>5-APDI - 版本历史</title>
	<link rel="self" type="application/atom+xml" href="https://arolstar52-zhtest.hf.space/index.php?action=history&amp;feed=atom&amp;title=5-APDI"/>
	<link rel="alternate" type="text/html" href="https://arolstar52-zhtest.hf.space/index.php?title=5-APDI&amp;action=history"/>
	<updated>2026-07-06T01:44:05Z</updated>
	<subtitle>在这个wiki上该页的修订历史</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://arolstar52-zhtest.hf.space/index.php?title=5-APDI&amp;diff=4604118&amp;oldid=prev</id>
		<title>imported&gt;Jimmy-bot：​机器人: 尚未清空的已重定向分类） （Cat:狡詐家藥物→Cat:策划药</title>
		<link rel="alternate" type="text/html" href="https://arolstar52-zhtest.hf.space/index.php?title=5-APDI&amp;diff=4604118&amp;oldid=prev"/>
		<updated>2025-08-15T10:24:05Z</updated>

		<summary type="html">&lt;p&gt;机器人: 尚未清空的已重定向分类） （&lt;a href=&quot;/index.php?title=Cat:%E7%8B%A1%E8%A9%90%E5%AE%B6%E8%97%A5%E7%89%A9&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;Cat:狡詐家藥物（页面不存在）&quot;&gt;Cat:狡詐家藥物&lt;/a&gt;→&lt;a href=&quot;/index.php?title=Cat:%E7%AD%96%E5%88%92%E8%8D%AF&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;Cat:策划药（页面不存在）&quot;&gt;Cat:策划药&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;新页面&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{Drugbox&lt;br /&gt;
| verifiedrevid = 415662463&lt;br /&gt;
| IUPAC_name = (±)-1-(2,3-dihydro-1&amp;#039;&amp;#039;H&amp;#039;&amp;#039;-inden-5-yl)propan-2-amine&lt;br /&gt;
| image = Indanylaminopropane.svg&lt;br /&gt;
| image_class = skin-invert-image&lt;br /&gt;
| chirality = [[Racemic mixture]]&lt;br /&gt;
| drug_name = Indanylaminopropane&lt;br /&gt;
&amp;lt;!-- Clinical data --&amp;gt;&lt;br /&gt;
| tradename =  &lt;br /&gt;
| pregnancy_category =  &lt;br /&gt;
| legal_UK = Class B&lt;br /&gt;
| legal_CA = Schedule III&lt;br /&gt;
| legal_DE = NpSG&lt;br /&gt;
| legal_status =&lt;br /&gt;
| routes_of_administration = Oral&lt;br /&gt;
&amp;lt;!-- Pharmacokinetic data --&amp;gt;&lt;br /&gt;
| bioavailability =  &lt;br /&gt;
| metabolism =  &lt;br /&gt;
| elimination_half-life =  &lt;br /&gt;
| excretion =  &lt;br /&gt;
&amp;lt;!-- Identifiers --&amp;gt;&lt;br /&gt;
| CAS_number_Ref = {{cascite|changed|??}}&lt;br /&gt;
| CAS_number = 13396-94-6&lt;br /&gt;
| UNII_Ref = {{fdacite|correct|FDA}}&lt;br /&gt;
| UNII = 4PH68L63R9&lt;br /&gt;
| ATC_prefix = none&lt;br /&gt;
| ATC_suffix =  &lt;br /&gt;
| PubChem = 192600&lt;br /&gt;
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}&lt;br /&gt;
| ChemSpiderID = 167142&lt;br /&gt;
| ChEMBL_Ref = {{ebicite|correct|EBI}}&lt;br /&gt;
| ChEMBL = 6842&lt;br /&gt;
&amp;lt;!-- Chemical data --&amp;gt;&lt;br /&gt;
| C=12 | H= 17 | N= 1&lt;br /&gt;
| smiles = c1cc(cc2c1CCC2)CC(N)C&lt;br /&gt;
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}&lt;br /&gt;
| StdInChI = 1S/C12H17N/c1-9(13)7-10-5-6-11-3-2-4-12(11)8-10/h5-6,8-9H,2-4,7,13H2,1H3&lt;br /&gt;
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}&lt;br /&gt;
| StdInChIKey = QYVNZHBQYJRLEX-UHFFFAOYSA-N&lt;br /&gt;
| synonyms = 5-APDI; 1-(5-Indanyl)-2-aminopropane; Indanylaminopropane; IAP; Indanametamine; 2-Aminopropylindane; 2-API; Indanylamphetamine&lt;br /&gt;
}}&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;{{PAGENAME}}&amp;#039;&amp;#039;&amp;#039;（化学名：5-(2-氨丙基)-2,3-二氢-1&amp;#039;&amp;#039;H&amp;#039;&amp;#039;-茚，{{langx|en|5-(2-Aminopropyl)-2,3-dihydro-1&amp;#039;&amp;#039;H&amp;#039;&amp;#039;-indene}}，别名有indanylaminopropane、2-aminopropylindane、indanametamine等）是一种[[氮化合物|含氮]][[有机化合物]]&amp;lt;ref name=&amp;quot;journalCharacterization of the “Indanylamphetamines”&amp;quot;&amp;gt;{{cite journal | vauthors = Casale JF, McKibben TD, Bozenko JS, Hays PA | title = Characterization of the &amp;quot;Indanylamphetamines&amp;quot; | journal = Microgram Journal | volume = 3 | issue = 1–2 | pages = 3–10 | year = 2005 | url = http://www.usdoj.gov/dea/programs/forensicsci/microgram/journal_v3/mj05_v3_pg1.html | access-date = 2009-08-06 | archive-url = https://web.archive.org/web/20090317054109/http://www.usdoj.gov/dea/programs/forensicsci/microgram/journal_v3/mj05_v3_pg1.html | archive-date = 2009-03-17 | url-status = dead }}&amp;lt;/ref&amp;gt;，化学式[[C12H17N|{{chem2|C12H17N}}]]，属于[[安非他命]][[衍生物]]&amp;lt;ref name=&amp;quot;pmid8246240&amp;quot;&amp;gt;{{cite journal | vauthors = Monte AP, Marona-Lewicka D, Cozzi NV, Nichols DE | title = Synthesis and pharmacological examination of benzofuran, indan, and tetralin analogues of 3,4-(methylenedioxy)amphetamine | journal = Journal of Medicinal Chemistry | volume = 36 | issue = 23 | pages = 3700–6 |date=November 1993 | pmid = 8246240 | doi = 10.1021/jm00075a027}}&amp;lt;/ref&amp;gt;，能作为[[迷幻药物]]&amp;lt;ref name=&amp;quot;pmid9526575&amp;quot;&amp;gt;{{cite journal | vauthors = Parker MA, Marona-Lewicka D, Kurrasch D, Shulgin AT, Nichols DE | title = Synthesis and pharmacological evaluation of ring-methylated derivatives of 3,4-(methylenedioxy)amphetamine (MDA) | journal = Journal of Medicinal Chemistry | volume = 41 | issue = 6 | pages = 1001–5 |date=March 1998 | pmid = 9526575 | doi = 10.1021/jm9705925| citeseerx = 10.1.1.688.9559 }}&amp;lt;/ref&amp;gt;。&lt;br /&gt;
&lt;br /&gt;
==参考文献== &lt;br /&gt;
{{reflist}}&lt;br /&gt;
&lt;br /&gt;
==外部链接==&lt;br /&gt;
* [http://www.erowid.org/chemicals/iap/iap.shtml The Vaults of Erowid - Indanylaminopropane]&lt;br /&gt;
* [http://designer-drug.com/pte/12.162.180.114/dcd/chemistry/iap.madmax.html MadMax - Illustrated Synthesis of Indanylaminopropane]&lt;br /&gt;
&lt;br /&gt;
[[Category:茚满]]&lt;br /&gt;
[[Category:策划药]]&lt;br /&gt;
[[Category:血清素释放剂]]&lt;/div&gt;</summary>
		<author><name>imported&gt;Jimmy-bot</name></author>
	</entry>
</feed>